MYB and cancer: When comparing the CNVs in early-stage primary samples that metastasize versus samples that do not, we observe a general increase in the frequency of CNVs (both amplifications and deletions) in samples that will give rise to metastasis, with a particular enrichment of amplifications in chromosome 6, encompassing cancer-associated genes such as MYB (Fig. 5b).